Company Overview - Tongcheng New Materials Group Co., Ltd. is a leading comprehensive new materials service provider in China, focusing on advanced chemical products [4] - The company operates in three main business segments: (i) electronic materials, (ii) tire rubber additives and other chemical products, and (iii) fully biodegradable materials [4] - The electronic materials segment includes semiconductor materials and display panel materials, primarily used in semiconductor and display panel production [4] - The tire rubber additives segment includes rubber resins and additives, which enhance the performance of rubber products [4] - The fully biodegradable materials segment focuses on PBAT products used in packaging materials and agricultural films [4] Financial Performance - Revenue for the fiscal years 2023 and 2024 was approximately RMB 2.937 billion and RMB 3.263 billion, respectively, with the first nine months of 2024 and 2025 showing revenues of RMB 2.420 billion and RMB 2.517 billion [5][7] - Profit for the fiscal years 2023 and 2024 was approximately RMB 404 million and RMB 534 million, respectively, with the first nine months of 2024 and 2025 showing profits of RMB 467 million and RMB 522 million [5][7] Market Position - In the electronic materials sector, the company ranked first among Chinese suppliers in the semiconductor photoresist market and the TFT array photoresist market for the first nine months of 2025 [4] - In the tire rubber additives segment, the company ranked first in both the global and Chinese markets for phenolic resin rubber additives during the same period [4] Industry Overview - The Chinese semiconductor photoresist market is expected to grow significantly, with ArF photoresist sales projected to increase from RMB 1 billion in 2020 to RMB 2.6 billion in 2024, representing a compound annual growth rate (CAGR) of 26.6% [8] - The CMP polishing pad market is also expected to grow, with sales projected to rise from RMB 1 billion in 2020 to RMB 2.3 billion in 2024, reflecting a CAGR of 22.8% [10] - The rubber additives market in China is projected to experience slight fluctuations, with total output expected to grow from RMB 202 billion in 2020 to RMB 215 billion in 2024, at a CAGR of 1.5% [14]

Summary of Key Points Core Viewpoint - The A-share IPO market is active with three companies approved for listing, while the Hong Kong IPO market continues to thrive, particularly in the innovative drug and high-end manufacturing sectors, with several key players making significant moves [2][6]. Group 1: A-share IPO Approvals - Three companies received approval for IPOs this week: Guangdong Huahui Intelligent Equipment Co., Ltd., Anhui Xinfeng New Energy Technology Co., Ltd., and Shandong Chunguang Technology Group Co., Ltd. [2][3][4]. - Huahui Intelligent focuses on high-end intelligent equipment and has seen rapid revenue growth, projecting over 4.2 billion yuan in revenue for 2024 and over 620 million yuan in net profit [3]. - Xinfeng Technology specializes in thermal management components for electric vehicles, with projected revenues of 6 billion yuan in 2024 and 13.81 billion yuan in 2025 [4][5]. - Chunguang Group leads in the production of soft magnetic ferrite powder, with revenues of 10.15 billion yuan in 2022 and a planned fundraising of 7.51 billion yuan for its IPO [5]. Group 2: Hong Kong IPO Market Activity - The Hong Kong IPO market welcomed five new listings, including four companies and one on the Sci-Tech Innovation Board, covering diverse sectors such as chemical new materials and cardiovascular medical devices [6][7]. - Guoen Technology debuted on the Hong Kong Stock Exchange, raising approximately 1 billion HKD, with plans for expansion in Thailand and domestic production [6]. - Beixin Life, the first medical device company listed on the Sci-Tech Innovation Board, saw its stock price surge by 183.33% on its first day, focusing on cardiovascular intervention devices [7]. - Leading companies in the PCB equipment sector, such as Dazhu CNC, raised significant funds for expansion into Southeast Asia, while Zhuozheng Medical and Muyuan Foods had mixed performances post-listing [8]. Group 3: Upcoming IPOs and Market Trends - The Hong Kong IPO market continues to be driven by hard technology, with companies like Danuo Pharmaceutical and Xian Dao Intelligent preparing for their listings, focusing on innovative drugs and lithium battery equipment [9][10]. - Danuo Pharmaceutical is set to raise funds for global clinical advancements, with its core product showing promising clinical data [9]. - Xian Dao Intelligent aims to raise 41.66 billion HKD, with a significant projected profit increase of 424% by 2025, expanding its services beyond lithium battery equipment [10]. - Wolong Nuclear Materials is also preparing for an IPO, focusing on new materials and global capacity expansion, with a fundraising target of up to 27.34 billion HKD [11].

【天晟新材：因涉嫌信息披露违法违规被证监会立案】天晟新材公告称，公司于2月6日收到中国证监会 立案告知书，因公司涉嫌信息披露违法违规，中国证监会决定对公司立案。本次立案可能涉及2023年度 关联交易未披露事项。目前公司生产经营正常，立案调查事项不会对公司正常生产经营活动产生重大影 响。公司将积极配合调查，严格履行信息披露义务。(智通财经) 证券代码:300169 证券简称:天晟新材 公告编号:2026-021 常州天晟新材料集团股份有限公司 关于收到中国证券监督管理委员会立案告知书的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 常州天晟新材料集团股份有限公司(以下简称"公司"或"天晟新材")于 2026 年2月6日收到中国证券监督管理委员会(以下简称"中国证监会")下发的《立 案告知书》(编号:证监立案字 0102026008号),因公司涉嫌信息披露违法违 规,根据《中华人民共和国证券法》《中华人民共和国行政处罚法》等法律法规, 中国证监会决定对公司立案。 经公司自查,本次立案可能涉及 2023年度关联交易未披露事项。截至本公 告披露目,公司尚未收到中 ...

Core Viewpoint - The Shijiazhuang Circular Chemical Park is undergoing a significant transformation, evolving from a traditional industrial base to a modern, high-quality chemical materials hub, integrating innovation, green development, and collaboration to support low-carbon urban construction [1][18]. Group 1: Industrial Transformation - The park is transitioning from a low-end to a high-end value chain, driven by a "second entrepreneurship" approach, aiming for high-quality development amidst market fluctuations and environmental constraints [3]. - The park has completed a significant upgrade from its initial version to a 3.0 version, establishing five industrial chains and focusing on the development of new chemical materials [3][18]. - A total investment of 220 billion yuan is planned for the green transformation project, which will enhance the integration of biomedicine, new-generation electronic information technology, and new chemical materials [3][18]. Group 2: Infrastructure Development - The park's area has expanded from 9.77 square kilometers to 15.04 square kilometers, providing additional industrial land for upgrades and reducing land costs to 300,000 yuan per mu, the lowest in the region [4]. - A 23 billion yuan energy island project is set to reduce gas costs for enterprises from approximately 350 yuan/ton to 160 yuan/ton, enhancing economic and green benefits [5]. - The logistics system has been improved with the launch of a 30 billion yuan international logistics park, which is expected to reduce logistics costs by over 30% [6]. Group 3: Safety and Innovation - The park has been recognized as a model for smart chemical parks, implementing a data-driven safety management system that monitors over 1,200 data points for production and safety [10]. - An AI model for risk monitoring has been developed, allowing for early warnings of potential risks, significantly enhancing proactive safety management [11]. - The establishment of a shared experimental center aims to facilitate the transition from laboratory results to small-scale production, supporting over 20 projects and achieving significant technological advancements [12]. Group 4: Ecosystem and Collaboration - The park is fostering a collaborative ecosystem where enterprises can efficiently utilize resources, exemplified by the transformation of by-products into high-value chemicals [14]. - Key projects are being introduced to build a modern chemical materials industry cluster, ensuring long-term vitality and competitiveness [15]. - The park aims to create a new industrial landscape by integrating chemical new materials with biomedicine and electronic information industries, promoting collaborative innovation [15][18].

Core Viewpoint - The collaboration between Kunlun Trust and leading companies in the chemical new materials sector, Zhejiang Satellite Chemical and Jinda Technology, successfully implemented a trial production of green materials, showcasing a new financial solution for industrial chain collaboration [1][15][16]. Group 1: Industry Context - The chemical new materials industry is accelerating towards high-end and green upgrades, necessitating the integration of financial tools into the operational logic of the real economy [1][15]. - Satellite Chemical, a publicly listed company with original technology advantages, utilizes natural gas separation of light hydrocarbons instead of traditional crude oil processes, resulting in products that are low-carbon, low-cost, and high-purity [1][15][16]. Group 2: Financial Innovation - Kunlun Trust has developed an innovative "Trust + SPV" supply chain finance model, enhancing the efficiency of trade execution and resource allocation during the trial phase [1][22]. - The trust structure provides a robust framework for compliance and risk isolation, while the SPV company facilitates efficient capital flow and logistics [22]. Group 3: Collaboration Outcomes - The trial product, polystyrene, benefits from a stable and cost-controlled supply chain, helping Jinda Technology mitigate the pressures of traditional petrochemical raw material price fluctuations [16][22]. - The successful trial has laid a solid foundation for further deepening cooperation between the involved parties [16]. Group 4: Future Directions - Kunlun Trust aims to align with national strategies and key industry needs, expanding its "Trust + Supply Chain" service system to enhance comprehensive financial service capabilities in energy, chemical, advanced manufacturing, and green industries [22].

Group 1 - On February 4, Guoen Technology officially listed on the Hong Kong Stock Exchange, becoming the first company in Shandong Province to achieve A+H share dual listing in 2026 and the eighth H-share listed company in Qingdao [1] - On its first trading day, Guoen Technology's stock surged by 37.06%, reaching a market capitalization of HKD 14.864 billion, indicating strong market performance [1] - The company specializes in chemical new materials and health sectors, focusing on upstream and downstream products such as gelatin and collagen [1] Group 2 - The H-share issuance involved 30 million shares, raising approximately HKD 1 billion, which will be used for expanding production capacity in Thailand and domestically, establishing regional headquarters, and upgrading existing production bases [1] - The IPO received significant market recognition, with the public offering being oversubscribed by 2,251.85 times and the international placement by 10.03 times, making it one of the most highly subscribed new stocks recently [1] - Guoen Technology's successful listing contributes to the growth of the Qingdao Stock Exchange, which now has 21 listed companies and has raised over RMB 13 billion in IPO funds [2]

Group 1 - The company has submitted an application for issuing H shares to the Hong Kong Stock Exchange, with the relevant filing materials accepted by the China Securities Regulatory Commission [1] - In the large chemical sector, the company aims to enhance its profitability by extending its upstream and downstream industrial chain, including several strategic investment projects in polystyrene production [1] - The company plans to actively promote the recovery of production capacity at Guoen Chemical (Dongming) and integrate internal resources to establish a complete vertical industrial chain from monomers to end products [1] Group 2 - In the health sector, the company is focusing on the "collagen+" strategy, with its subsidiary Dongbao Biological leading in the collagen field and expanding its hollow capsule production capacity [2] - Dongbao Biological has an annual production capacity of 13,500 tons of gelatin, while Yiqing Biological has a capacity of 39 billion hollow capsules, which is expected to increase significantly after the completion of its new production project [2] - The company anticipates a significant increase in performance due to the expansion of hollow capsule production capacity, entering a growth phase [2] Group 3 - The company expects to achieve net profits of 742 million, 947 million, and 1.095 billion yuan from 2025 to 2027, with corresponding price-to-earnings ratios of 12.57X, 9.84X, and 8.52X, respectively [2]

格隆汇2月5日丨永冠新材(603681.SH)公布，2026年2月5日，公司之全资子公司江西振冠环保可降解新 材料有限公司、江西连冠新材料科技有限公司共计收到政府补助4000万元，均为与收益相关的政府补 助，占公司最近一个会计年度经审计归属于上市公司股东的净利润的24.50%。 ...

Core Viewpoint - The company, Jushi Chemical, has been found guilty of financial fraud, inflating its revenue and costs in its 2023 semi-annual report, leading to significant penalties and potential investor claims [1][3]. Group 1: Financial Fraud Details - Jushi Chemical inflated its revenue by 157 million yuan and its operating costs by 158 million yuan in the first half of 2023 [1][3]. - The company utilized three main methods for inflating its financial figures, including engaging in fictitious trades with controlled companies, manipulating trade chains, and reporting sales of goods that were never actually shipped [5]. - The inflated figures represented 8.32% of total revenue, 8.51% of total costs, and resulted in a profit reduction of 166.29 million yuan, accounting for 6.81% of total profit [5]. Group 2: Investor Claims - Investors who purchased Jushi Chemical shares between August 29, 2023, and November 21, 2025, and suffered losses are eligible to file claims [3]. - The formal penalties serve as strong evidence for investors seeking compensation for their losses due to the company's fraudulent activities [3]. Group 3: Company Performance Outlook - Jushi Chemical has been experiencing deteriorating business conditions, with projections indicating a significant decline in performance for 2024 and 2025 [7]. - The company is expected to report a net loss of between 90 million and 120 million yuan for the year 2025, marking its second consecutive year of losses [7]. - The decline in revenue is attributed to a significant drop in the liquefied petroleum gas business, heavily influenced by fluctuations in international crude oil prices [7].

记者丨李山 编辑丨黄敏 虚增收入1.57亿元、虚增营业成本1.58亿元——聚石化学（688669）2023年半年度财务造假细 节随着监管罚单正式曝光。伴随调查定性落地，相关投资者索赔窗口也已明确：在2023年8月 29日至2025年11月21日期间买入该股票并遭受损失的投资者，可 关注"投资快报"公众号，通 过右侧"股民索赔"菜单栏参与索赔。 投资者索赔条件明确 聚石化学于2026年2月3日发布公告称，收到中国证监会广东监管局的《行政处罚决定书》。 经查明，该公司及其子公司通过开展虚假贸易业务虚增收入、成本和利润，2023年半年度虚增 营业收入合计1.57亿元、虚增营业成本合计1.58亿元。 同时，上海证券交易所也对聚石化学及有关责任人予以公开谴责，并对该公司及时任董事长陈 钢、时任总经理周侃、时任财务总监伍洋、时任董事会秘书包伟予以监管警示。 根据相关法律规定，投资者需要同时满足以下条件才享有索赔资格：在上市公司实施了虚假陈 述行为后购买股票，并且一直持有股票到上市公司虚假陈述行为被公开揭露或者自行更正后。 而此次正式处罚的送达也为投资者索赔提供了有力证据。 上海沪紫律师事务所刘鹏律师表示，在2023年8月 ...